Moshe Manor

2019

In 2019, Moshe Manor earned a total compensation of $615.6K as President and Chief Executive Officer at Protalix BioTherapeutics, a 14% decrease compared to previous year.

Compensation breakdown

Option Awards$39,337
Salary$362,073
Other$214,221
Total$615,631

Manor received $362.1K in salary, accounting for 59% of the total pay in 2019.

Manor also received $39.3K in option awards and $214.2K in other compensation.

Rankings

In 2019, Moshe Manor's compensation ranked 11,120th out of 13,971 executives tracked by ExecPay. In other words, Manor earned more than 20.4% of executives.

ClassificationRankingPercentile
All
11,120
out of 13,971
20th
Division
Manufacturing
4,492
out of 5,692
21st
Major group
Chemicals And Allied Products
1,758
out of 2,189
20th
Industry group
Drugs
1,512
out of 1,875
19th
Industry
Biological Products, Except Diagnostic Substances
337
out of 389
13th
Source: SEC filing on April 15, 2020.

Manor's colleagues

We found six more compensation records of executives who worked with Moshe Manor at Protalix BioTherapeutics in 2019.

2019

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2019

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2019

Dror Bashan

Protalix BioTherapeutics

Chief Executive Officer

2019

Yaron Naos

Protalix BioTherapeutics

Senior Vice President, Operations

2019

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2019

Eyal Rubin

Protalix BioTherapeutics

Chief Financial Officer

News

You may also like